I explained that any partnerships would be officially announced through the company. The claim from Twitter was partially tied to Chandra adding GS and Eli Lilly as a hashtag, AND an article from Eli Lilly regarding their mAbs.
Regarding anything official, the only thing we know for certain is that ENZC asked "Eli Lilly about their mAbs" in the Oct 19 PR, which infers we had a discussion with them at some capacity. We also only know that ENZC themselves speculated in the press release that Lilly was maybe having methodology production issues, which we could infer that our technology could potentially resolve if we licensed.
Who knows. Speculative, obviously but I do see a valid claim is that Eli Lilly is potentially licensing our tech.